EUVIMEDEUVIMED entdecken
Crossref

Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis

Hiroaki Hori, Fuyuko Yoshida, Ikki Ishida, Junko Matsuo, Shintaro Ogawa, Kotaro Hattori, Yoshiharu Kim, Hiroshi Kunugi

Journal of Affective Disorders · 2024-03 · 349 · 244-253

DOI: 10.1016/j.jad.2024.01.080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024-03. Verfasst von Hiroaki Hori und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Ment…. Hauptthemen laut MEDLINE: Depressive Disorder, Receptors, Glucocorticoid. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While depression has been associated with alterations in the hypothalamic-pituitary adrenal (HPA) axis function, there is still controversy regarding the nature and extent of the dysfunction, such as in the debate about hypercortisolism vs. hypocortisolism. It may therefore be necessary to understand whether and how HPA axis function in depression is linked to mRNA expression of key genes regulating this system. METHODS: We studied 163 depressed outpatients, most of whom were chronically ill, and 181 healthy controls. Blood mRNA expression levels of NR3C1 (including GRα, GRβ, and GR-P isoforms), FKBP4, and FKBP5 were measured at baseline. HPA axis feedback sensitivity was measured by the dexamethasone (Dex)/corticotropin-releasing hormone (CRH) test. The association between mRNA expression levels and HPA axis feedback sensitivity was examined. RESULTS: Compared to controls, patients showed significantly higher expression of GRα and lower expression of FKBP5, and higher post-Dex cortisol levels, even after controlling for age and sex. FKBP5 expression was significantly positively correlated with cortisol levels in patients, while GRα expression was significantly negatively correlated with cortisol levels in controls. LIMITATIONS: Most patients were taking psychotropic medications. The large number of correlation tests may have caused type I errors. CONCLUSIONS: The tripartite relationship between depression, mRNA expression of GR and FKBP5, and HPA axis function suggests that the altered gene expression affects HPA axis dysregulation and, as a result, impacts the development and/or illness course of depressive disorder. The combination of increased GRα expression and decreased FKBP5 expression may serve as a biomarker for chronic depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Depressive DisorderReceptors, GlucocorticoidHumansCorticotropin-Releasing HormoneDexamethasoneHydrocortisoneHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemRNA, MessengerTacrolimus Binding Protein 5

Stichwörter der Autor:innen

CortisolDepressionFKBP5Gene expressionGlucocorticoid receptor (GR)Hypothalamic-pituitary adrenal (HPA) axis

Substanzen

Corticotropin-Releasing HormoneDexamethasoneHydrocortisoneReceptors, GlucocorticoidRNA, MessengerTacrolimus Binding Protein 5

Autor:innen und Institutionen

  • Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Mental Disorder Research, National Institute of Neuroscience, National Cen…
  • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan.
  • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Psychiatry, National Center Hospital, National Center of Neurology and…
  • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan; Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Department of Mental Disorder Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan. Electr…

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology
  • National Center of Neurology and Psychiatry

Zitieren

APA

Hori, H., Yoshida, F., Ishida, I., Matsuo, J., Ogawa, S., Hattori, K., Kim, Y., & Kunugi, H. (2024). Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis. Journal of Affective Disorders, 349, 244-253. https://doi.org/10.1016/j.jad.2024.01.080

Vancouver

Hori H, Yoshida F, Ishida I, Matsuo J, Ogawa S, Hattori K, et al. Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis. Journal of Affective Disorders. 2024;349:244-253. doi:10.1016/j.jad.2024.01.080

BibTeX
@article{Hori2024,
  author = {Hori, Hiroaki and Yoshida, Fuyuko and Ishida, Ikki and Matsuo, Junko and Ogawa, Shintaro and Hattori, Kotaro and Kim, Yoshiharu and Kunugi, Hiroshi},
  title = {Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis},
  journal = {Journal of Affective Disorders},
  year = {2024},
  volume = {349},
  pages = {244--253},
  doi = {10.1016/j.jad.2024.01.080}
}
Kostenlos starten →